Antibiotice
Antibiotice S.A., a prominent player in the pharmaceutical industry, is headquartered in Iaşi, Romania. Established in 1955, the company has evolved into a leading manufacturer of generic antibiotics and other essential medications, serving both domestic and international markets. With a strong focus on research and development, Antibiotice has achieved significant milestones, including the production of innovative formulations and a robust portfolio of over 200 products. The company’s core offerings include injectable antibiotics, oral medications, and topical treatments, distinguished by their high quality and efficacy. Antibiotice is recognised for its commitment to sustainability and compliance with international standards, positioning itself as a trusted partner in healthcare. With a solid market presence in Europe and beyond, Antibiotice continues to contribute to global health through its dedication to pharmaceutical excellence.
DitchCarbon Score
How does Antibiotice's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Antibiotice's score of 17 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Antibiotice's reported carbon emissions
In 2022, Antibiotice reported total carbon emissions of approximately 9,937,240 kg CO2e, which includes 8,947,850 kg CO2e from Scope 1 emissions and 5,259,210 kg CO2e from Scope 2 emissions. This marked a significant reduction from previous years, with total emissions of about 11,203,000 kg CO2e in 2021 and 11,294,000 kg CO2e in 2020. The company has demonstrated a commitment to reducing its carbon footprint, with a focus on improving emissions intensity, achieving approximately 0.03 kg CO2e per 1,000 LEI of goods produced in 2022. Antibiotice has set near-term reduction targets and is actively working towards enhancing its sustainability practices within the pharmaceuticals, biotechnology, and life sciences sector. While the company has not committed to a net-zero target, it remains dedicated to ongoing emissions reductions and has made strides in lowering its carbon intensity over recent years. The company’s headquarters is located in Romania, and it continues to align its operations with industry standards for climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 9,141,900 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 3,604,070 | 0,000,000 | 0,000,000 | - |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Antibiotice is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
